A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients

T. S. Yang, S. N. Lu, Y. Chao, I. S. Sheen^*, C. C. Lin, T. E. Wang, S. C. Chen, J. H. Wang, L. Y. Liao, J. A. Thomson, J. Wang-Peng, P. J. Chen, L. T. Chen

^*Corresponding author for this work